Aardvark Therapeutics, Inc. Common Stock Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold00000000
Gross Profit00000000
R&D Expenses16.6M14.3M13.7M13.1M7.8M8.1M4.1M4.0M
Operating Expenses22.5M18.7M17.7M15.8M10.5M9.4M5.1M6.1M
Operating Income-22.5M-18.7M-17.7M-15.8M-10.5M-9.4M-5.1M-6.1M
Other Income / Gains876K1.1M1.4M1.5M1.2M671K909K624K
Net Income-21.6M-17.6M-16.3M-14.4M-9.3M-8.8M-4.2M-5.4M
EPS (Diluted)-0.99-0.81-0.75-0.66-0.43-0.40-0.20-0.25
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses5.9M4.4M4.0M2.7M2.7M1.4M1.0M2.0M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses5.9M4.4M4.0M2.7M2.7M1.4M1.0M2.0M
Other Expenses000000014K
Cost And Expenses22.5M18.7M17.7M15.8M10.5M9.4M5.1M6.1M
Interest Income889K1.1M1.4M1.5M1.2M717K1.0M594K
Interest Expense00000000
Depreciation And Amortization11K10K10K11K5K08K48K
Ebitda-21.6M-17.6M-16.3M-14.4M-9.3M-8.8M-4.2M-6.0M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-21.6M-17.6M-16.3M-14.4M-9.3M-8.8M-4.2M-5.4M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.99-0.81-0.75-0.66-0.43-0.40-0.20-0.25
Weighted Average Shs Out21.8M21.8M21.7M21.7M21.7M21.7M21.4M21.4M
Weighted Average Shs Out Dil21.8M21.8M21.7M21.7M21.7M21.7M21.4M21.4M